{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T19:48:13Z","timestamp":1725997693303},"publisher-location":"Cham","reference-count":83,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319945910"},{"type":"electronic","value":"9783319945934"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-94593-4_10","type":"book-chapter","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T08:05:11Z","timestamp":1539763511000},"page":"267-281","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using Systems Biology and Mathematical Modeling Approaches in the Discovery of Therapeutic Targets for Spinal Muscular Atrophy"],"prefix":"10.1007","author":[{"given":"Matthew E. R.","family":"Butchbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","volume":"12","author":"C Andreassi","year":"2004","unstructured":"Andreassi C, Angelozzi C, Tiziano FD, Vitali T, De Vincenzi E, Boninsegna A, et al. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet. 2004;12:59\u201365.","journal-title":"Eur J Hum Genet"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","volume":"10","author":"C Andreassi","year":"2001","unstructured":"Andreassi C, Jarecki J, Zhou J, Coovert DD, Monani UR, Chen X, et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet. 2001;10:2841\u20139.","journal-title":"Hum Mol Genet"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jmg.2007.051177","volume":"45","author":"C Angelozzi","year":"2008","unstructured":"Angelozzi C, Borgo F, Tiziano FD, Martella A, Neri G, Brahe C. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. J Med Genet. 2008;45:29\u201331.","journal-title":"J Med Genet"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10409238.2011.556597","volume":"46","author":"A Ay","year":"2011","unstructured":"Ay A, Arnosti DN. Mathematical modeling of gene expression: a guide for the perplexed biologist. Crit Rev Biochem Mol Biol. 2011;46:137\u201351.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/bse0450195","volume":"45","author":"JR Banga","year":"2008","unstructured":"Banga JR, Balsa-Canto E. Parameter estimation and optimal experimental design. Essays Biochem. 2008;45:195.","journal-title":"Essays Biochem"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/GIM.0b013e3182017c05","volume":"13","author":"S Ben-Shachar","year":"2011","unstructured":"Ben-Shachar S, Orr-Urtreger A, Bardugo E, Shomrat R, Yaron Y. Large-scale population screening for spinal muscular atrophy: clinical implications. Genet Med. 2011;13:110\u20134.","journal-title":"Genet Med"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/jmg.2010.079004","volume":"47","author":"S Bernal","year":"2010","unstructured":"Bernal S, Al\u00edas L, Barcel\u00f3 MJ, Also-Rallo E, Mart\u00ednez-Hern\u00e1ndez R, G\u00e1mez J, et al. The c.859G>C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor. J Med Genet. 2010;47:640\u20132.","journal-title":"J Med Genet"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","volume":"19","author":"AK Bevan","year":"2010","unstructured":"Bevan AK, Hutchinson KR, Foust KD, Braun L, McGovern VL, Schmelzer L, et al. Early heart failure in the SMN\u03947 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum Mol Genet. 2010;19:3895\u2013905.","journal-title":"Hum Mol Genet"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"12063","DOI":"10.1523\/JNEUROSCI.0608-15.2015","volume":"35","author":"O Biondi","year":"2015","unstructured":"Biondi O, Branchu J, Ben Salah A, Houdebine L, Bertin L, Chali F, et al. IGF-1R reduction triggers neuroprotective signaling pathways in spinal muscular atrophy mice. J Neurosci. 2015;35:12063\u201379.","journal-title":"J Neurosci"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"11288","DOI":"10.1523\/JNEUROSCI.1764-10.2010","volume":"30","author":"O Biondi","year":"2010","unstructured":"Biondi O, Branchu J, Sanchez G, Lancelin C, Deforges S, Lopes P, et al. In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons and enhances SMN2 gene expression in severe spinal muscular atrophy mice. J Neurosci. 2010;30:11288\u201399.","journal-title":"J Neurosci"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"5907","DOI":"10.1113\/jphysiol.2012.238196","volume":"590","author":"O Biondi","year":"2012","unstructured":"Biondi O, Lopes P, Desseille C, Branchu J, Chali F, Ben Salah A, et al. Physical exercise reduces cardiac defects in type 2 spinal muscular atrophy-like mice. J Physiol. 2012;590:5907\u201325.","journal-title":"J Physiol"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1093\/hmg\/ddu052","volume":"23","author":"M Bowerman","year":"2014","unstructured":"Bowerman M, Michalski JP, Beauvais A, Murray LM, DeRepentigny Y, Kothary R. Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology. Hum Mol Genet. 2014;23:3432\u201344.","journal-title":"Hum Mol Genet"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ana.23582","volume":"72","author":"M Bowerman","year":"2012","unstructured":"Bowerman M, Swoboda KJ, Michalski JP, Wang GS, Reeks C, Beauvais A, et al. Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann Neurol. 2012;72:256\u201368.","journal-title":"Ann Neurol"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1523\/JNEUROSCI.2728-12.2013","volume":"33","author":"J Branchu","year":"2013","unstructured":"Branchu J, Biondi O, Chali F, Collin T, Leroy F, Mamchaoui K, et al. Shift from extracellular signal-related kinase to AKT\/cAMP response element-binding protein pathway increases survival-motor-neuron expression in spinal-muscular-atrophy-like mice and patient cells. J Neurosci. 2013;33:4280\u201394.","journal-title":"J Neurosci"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/MCB.01262-08","volume":"29","author":"BG Burnett","year":"2009","unstructured":"Burnett BG, Mu\u00f1oz E, Tandon A, Kwon DY, Sumner CJ, Fischbeck KH. Regulation of SMN protein stability. Mol Cell Biol. 2009;29:1107\u201315.","journal-title":"Mol Cell Biol"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmolb.2016.00007","volume":"3","author":"MER Butchbach","year":"2016","unstructured":"Butchbach MER. Copy number variations in the survival motor neuron genes: implications for spinal muscular atrophy and other neurodegenerative diseases. Front Mol Biosci. 2016;3:7.","journal-title":"Front Mol Biosci"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ddmod.2004.07.001","volume":"1","author":"MER Butchbach","year":"2004","unstructured":"Butchbach MER, Burghes AHM. Perspectives on models of spinal muscular atrophy for drug discovery. Drug Discov Today Dis Model. 2004;1:151\u20136.","journal-title":"Drug Discov Today Dis Model"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/adt.2014.587","volume":"12","author":"JJ Cherry","year":"2014","unstructured":"Cherry JJ, Kobayashi DT, Lynes MM, Naryshkin NN, Tiziano FD, Zaworksi PG, et al. Assays for the identification and prioritization of drug candidates for spinal muscular atrophy. Assay Drug Dev Technol. 2014;12:315\u201341.","journal-title":"Assay Drug Dev Technol"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.1884910","volume":"24","author":"S Cho","year":"2010","unstructured":"Cho S, Dreyfuss G. A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev. 2010;24:438\u201342.","journal-title":"Genes Dev"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"DD Coovert","year":"1997","unstructured":"Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet. 1997;6:1205\u201314.","journal-title":"Hum Mol Genet"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","volume":"3","author":"TO Crawford","year":"1996","unstructured":"Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis. 1996;3:97\u2013110.","journal-title":"Neurobiol Dis"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1046\/j.1471-0528.2002.02083.x","volume":"109","author":"I Cusc\u00f3","year":"2002","unstructured":"Cusc\u00f3 I, Barcel\u00f3 MJ, Soler C, Parra J, Baiget M, Tizzano E. Prenatal diagnosis for risk of spinal muscular atrophy. Br J Obstet Gynaecol. 2002;109:1244\u20139.","journal-title":"Br J Obstet Gynaecol"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cjce.20025","volume":"86","author":"P Dhurjati","year":"2008","unstructured":"Dhurjati P, Mahadevan R. Systems biology: the synergistics interplay between biology and mathematics. Can J Chem Eng. 2008;86:127\u201341.","journal-title":"Can J Chem Eng"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1478-5382(03)02370-9","volume":"1","author":"A Funahashi","year":"2003","unstructured":"Funahashi A, Morohashi M, Kitano H, Tanimura N. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. Biosilico. 2003;1:159\u201362.","journal-title":"Biosilico"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1093\/hmg\/ddv127","volume":"24","author":"SE Gombash","year":"2015","unstructured":"Gombash SE, Cowley CJ, Fitzgerald JA, Iyer CC, Fried D, McGovern VL, et al. SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum Mol Genet. 2015;24:3847\u201360.","journal-title":"Hum Mol Genet"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.20548","volume":"58","author":"SM Grzeschik","year":"2005","unstructured":"Grzeschik SM, Ganta M, Prior TW, Heavlin WD, Wang CH. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells. Ann Neurol. 2005;58:194\u2013202.","journal-title":"Ann Neurol"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-1326-6-24","volume":"6","author":"T Hao Le","year":"2011","unstructured":"Hao Le T, Burghes AHM, Beattie CE. Generation and characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene. Mol Neurodegener. 2011;6:24.","journal-title":"Mol Neurodegener"},{"key":"10_CR28","first-page":"351","volume":"4","author":"NIF Harahap","year":"2015","unstructured":"Harahap NIF, Nurputra DK, Rochmah MA, Shima A, Morisada N, Takarada T, et al. Salbutamol inhibits ubiquitin-mediated survival motor neuron protein degradation in spinal muscular atrophy cells. Biochem Biophys Rep. 2015;4:351\u20136.","journal-title":"Biochem Biophys Rep"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","volume":"19","author":"CR Heier","year":"2010","unstructured":"Heier CR, Satta R, Lutz C, DiDonato CJ. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet. 2010;19:3906\u201318.","journal-title":"Hum Mol Genet"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/jmg.2009.066969","volume":"46","author":"BC Hendrickson","year":"2009","unstructured":"Hendrickson BC, Donohoe C, Akmaev VR, Sugarman EA, Labrousse P, Boguslavskiy L, et al. Differences in SMN1 allele frequencies among ethnic groups within North America. J Med Genet. 2009;46:641\u20134.","journal-title":"J Med Genet"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","volume":"22","author":"S Hoops","year":"2006","unstructured":"Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, et al. COPASI\u2014a complex pathway simulator. Bioinformatics. 2006;22:3067\u201374.","journal-title":"Bioinformatics"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/71709","volume":"24","author":"HM Hsieh-Li","year":"2000","unstructured":"Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH, et al. A mouse model for spinal muscular atrophy. Nat Genet. 2000;24:66\u201370.","journal-title":"Nat Genet"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/bioinformatics\/btg015","volume":"19","author":"M Hucka","year":"2003","unstructured":"Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, et al. The systems biology markup language (SBML): a medium for representaion and exchange of biochemical network models. Bioinformatics. 2003;19:524\u201331.","journal-title":"Bioinformatics"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/bse0450177","volume":"45","author":"B Ingalls","year":"2008","unstructured":"Ingalls B. Sensitivity analysis: from model parameters to system behaviour. Essays Biochem. 2008;45:177\u201393.","journal-title":"Essays Biochem"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1093\/hmg\/ddi205","volume":"14","author":"J Jarecki","year":"2005","unstructured":"Jarecki J, Chen X, Bernardino A, Coovert DD, Whitney M, Burghes AHM, et al. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Hum Mol Genet. 2005;14:2003\u201318.","journal-title":"Hum Mol Genet"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2174\/156802611795589629","volume":"11","author":"R Kleppe","year":"2011","unstructured":"Kleppe R, Krakstad C, Selheim F, Kopperud R, D\u00f8skeland SO. The cAMP-dependent protein kinase pathway as therapeutic target\u2014possibilities and pitfalls. Curr Top Med Chem. 2011;11:1393\u2013405.","journal-title":"Curr Top Med Chem"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33:831\u201346.","journal-title":"Neurol Clin"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.nmd.2007.05.005","volume":"17","author":"R Labrum","year":"2007","unstructured":"Labrum R, Rodda J, Krause A. The molecular basis of spinal muscular atrophy (SMA) in South African black patients. Neuromuscul Disord. 2007;17:684\u201392.","journal-title":"Neuromuscul Disord"},{"key":"10_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nrg3885","volume":"16","author":"N Nov\u00e8re Le","year":"2015","unstructured":"Le Nov\u00e8re N. Quantitative and logic modelling of molecular and gene networks. Nat Rev Genet. 2015;16:146\u201358.","journal-title":"Nat Rev Genet"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nbt.1558","volume":"27","author":"N Nov\u00e8re Le","year":"2009","unstructured":"Le Nov\u00e8re N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, et al. The systems biology graphical notation. Nat Biotechnol. 2009;27:735\u201341.","journal-title":"Nat Biotechnol"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155\u201365.","journal-title":"Cell"},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","volume":"15","author":"Q Liu","year":"1996","unstructured":"Liu Q, Dreyfuss G. A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 1996;15:3555\u201365.","journal-title":"EMBO J"},{"key":"10_CR43","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","volume":"9","author":"CL Lorson","year":"2000","unstructured":"Lorson CL, Androphy EJ. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet. 2000;9:259\u201365.","journal-title":"Hum Mol Genet"},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A. 1999;96:6307\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR45","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.chembiol.2004.08.024","volume":"11","author":"MR Lunn","year":"2004","unstructured":"Lunn MR, Root DE, Martino AM, Flaherty SP, Kelley BP, Coovert DD, et al. Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem Biol. 2004;11:1489\u201393.","journal-title":"Chem Biol"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/gtmb.2011.0149","volume":"16","author":"J Lyahyai","year":"2012","unstructured":"Lyahyai J, Sbiti A, Barkat A, Ratbi I, Sefiani A. Spinal muscular atrophy carrier frequency and estimated prevalence of the disease in Moroccan newborns. Genet Test Mol Biomarkers. 2012;16:215\u20138.","journal-title":"Genet Test Mol Biomarkers"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"e115473","DOI":"10.1371\/journal.pone.0115473","volume":"9","author":"SG Mack","year":"2014","unstructured":"Mack SG, Cook DJ, Dhurjati P, Butchbach MER. Systems biology investigation of cAMP modulation to increase SMN levels for treatment of spinal muscular atrophy. PLoS One. 2014;9:e115473.","journal-title":"PLoS One"},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-1-4939-3283-2_18","volume":"1386","author":"AL MacLean","year":"2016","unstructured":"MacLean AL, Harrington HA, Stumpf MPH, Byrne HM. Mathematical and statistical techniques for systems medicine: the Wnt signaling pathway as a case study. Methods Mol Biol. 2016;1386:405\u201339.","journal-title":"Methods Mol Biol"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"14803","DOI":"10.1074\/jbc.M308225200","volume":"279","author":"S Majumder","year":"2004","unstructured":"Majumder S, Varadharaj S, Ghoshal K, Monani U, Burghes AHM, Jacob ST. Identification of a novel cyclic AMP response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene. J Biol Chem. 2004;279:14803\u201311.","journal-title":"J Biol Chem"},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00439-006-0245-7","volume":"120","author":"VB Mattis","year":"2006","unstructured":"Mattis VB, Rai R, Wang J, Chang CWT, Coady T, Lorson CL. Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts. Hum Genet. 2006;120:589\u2013601.","journal-title":"Hum Genet"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-59745-525-1_2","volume":"500","author":"P Mendes","year":"2009","unstructured":"Mendes P, Hoops S, Sahle S, Gauges R, Dada J, Kummer U. Computational models of biochemical networks using COPASI. Methods Mol Biol. 2009;500:17\u201359.","journal-title":"Methods Mol Biol"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.nbd.2010.01.006","volume":"38","author":"M Michaud","year":"2010","unstructured":"Michaud M, Arnoux T, Bielli S, Durand E, Rotrou Y, Jablonka S, et al. Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiol Dis. 2010;38:125\u201335.","journal-title":"Neurobiol Dis"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AHM, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet. 1999;8:1177\u201383.","journal-title":"Hum Mol Genet"},{"key":"10_CR54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","volume":"9","author":"UR Monani","year":"2000","unstructured":"Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, Le TT, et al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-\/- mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet. 2000;9:333\u20139.","journal-title":"Hum Mol Genet"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","volume":"2","author":"TL Munsat","year":"1992","unstructured":"Munsat TL, Davies KE. International SMA consortium meeting. Neuromuscul Disord. 1992;2:423\u20138.","journal-title":"Neuromuscul Disord"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/hmg\/ddm284","volume":"17","author":"T Novoyatleva","year":"2008","unstructured":"Novoyatleva T, Heinrich B, Tang Y, Benderska N, Butchbach MER, Lorson CL, et al. Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Hum Mol Genet. 2008;17:52\u201370.","journal-title":"Hum Mol Genet"},{"key":"10_CR57","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jmg.15.6.409","volume":"15","author":"J Pearn","year":"1978","unstructured":"Pearn J. Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet. 1978;15:409\u201313.","journal-title":"J Med Genet"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","volume":"85","author":"TW Prior","year":"2009","unstructured":"Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgeman SJ, et al. A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet. 2009;85:408\u201313.","journal-title":"Am J Hum Genet"},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00439-006-0186-1","volume":"120","author":"M Riessland","year":"2006","unstructured":"Riessland M, Brichta L, Hahnen E, Wirth B. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA\/protein levels in spinal muscular atrophy cells. Hum Genet. 2006;120:101\u201310.","journal-title":"Hum Genet"},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s004390100473","volume":"108","author":"CF Rochette","year":"2001","unstructured":"Rochette CF, Gilbert N, Simard LR. SMN gene duplication and emergence of the SMN2 gene occured in distinct hominids: SMN2 is unique to Homo sapiens. Hum Genet. 2001;108:255\u201366.","journal-title":"Hum Genet"},{"key":"10_CR61","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073807305673","volume":"22","author":"BS Russman","year":"2007","unstructured":"Russman BS. Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol. 2007;22:946\u201351.","journal-title":"J Child Neurol"},{"key":"10_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biosystems.2014.07.002","volume":"124","author":"A Ryll","year":"2014","unstructured":"Ryll A, Bucher J, Bonin A, Bongard S, Gon\u00e7alves E, Saez-Rodriguez J, et al. A model integration approach linking signalling and gene-regulatory logic with kinetic metabolic models. Biosystems. 2014;124:26\u201338.","journal-title":"Biosystems"},{"key":"10_CR63","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ana.24114","volume":"75","author":"M Sangar\u00e9","year":"2014","unstructured":"Sangar\u00e9 M, Hendrickson B, Sango HA, Chen K, Nofziger J, Amara A, et al. Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa. Ann Neurol. 2014;75:525\u201332.","journal-title":"Ann Neurol"},{"key":"10_CR64","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/bioinformatics\/bti799","volume":"22","author":"H Schmidt","year":"2006","unstructured":"Schmidt H, Jirstrand M. Systems Biology Toolbox for MATLAB: a computational platform for research in systems biology. Bioinformatics. 2006;22:514\u20135.","journal-title":"Bioinformatics"},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","volume":"94","author":"B Schrank","year":"1997","unstructured":"Schrank B, G\u00f6tz R, Gunnersen JM, Ure JM, Toyka KV, Smith AG, et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A. 1997;94:9920\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR66","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.yjmcc.2012.01.005","volume":"52","author":"M Shababi","year":"2012","unstructured":"Shababi M, Habibi J, Ma L, Glascock JJ, Sowers JR, Lorson CL. Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy. J Mol Cell Cardiol. 2012;52:1074\u201382.","journal-title":"J Mol Cell Cardiol"},{"key":"10_CR67","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","volume":"19","author":"M Shababi","year":"2010","unstructured":"Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL. Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet. 2010;19:4059\u201371.","journal-title":"Hum Mol Genet"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/joa.12083","volume":"224","author":"M Shababi","year":"2014","unstructured":"Shababi M, Lorson CL, Rudnik-Sch\u00f6neborn S. Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease? J Anat. 2014;224:15\u201328.","journal-title":"J Anat"},{"key":"10_CR69","doi-asserted-by":"publisher","first-page":"e17067","DOI":"10.1371\/journal.pone.0017067","volume":"6","author":"YN Su","year":"2011","unstructured":"Su YN, Hung CC, Lin SY, Chen FY, Chern JPS, Tsai C, et al. Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study. PLoS One. 2011;6:e17067.","journal-title":"PLoS One"},{"key":"10_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs AM, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of > 72400 specimens. Eur J Hum Genet. 2012;20:27\u201332.","journal-title":"Eur J Hum Genet"},{"key":"10_CR71","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA, Perhac JS, Hill B, Coovert DD, et al. Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol. 2003;54:647\u201354.","journal-title":"Ann Neurol"},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/jm061475p","volume":"51","author":"J Thurmond","year":"2008","unstructured":"Thurmond J, Butchbach MER, Palomo M, Pease B, Rao M, Bedell L, et al. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. J Med Chem. 2008;51:449\u201369.","journal-title":"J Med Chem"},{"key":"10_CR73","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmg.2010.080366","volume":"47","author":"FD Tiziano","year":"2010","unstructured":"Tiziano FD, Lomastro R, Pinto AM, Messina S, D'Amico A, Fiori S, et al. Salbutamol increases survival motor neuron (SMN) transcript levels in leukocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. J Med Genet. 2010;47:856\u20138.","journal-title":"J Med Genet"},{"key":"10_CR74","doi-asserted-by":"publisher","first-page":"E1110","DOI":"10.1002\/humu.21173","volume":"31","author":"M Vezain","year":"2010","unstructured":"Vezain M, Saukkonen AM, Goina E, Touraine R, Manel V, Toutain A, et al. A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy. Hum Mutat. 2010;31:E1110\u201325.","journal-title":"Hum Mutat"},{"key":"10_CR75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ana.21634","volume":"65","author":"P Villoslada","year":"2009","unstructured":"Villoslada P, Steinman L, Baranzini SE. Systems biology and its application to the understanding of neurological diseases. Ann Neurol. 2009;65:124\u201339.","journal-title":"Ann Neurol"},{"key":"10_CR76","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1128\/MCB.13.5.2822","volume":"13","author":"BE Wadzinski","year":"1993","unstructured":"Wadzinski BE, Wheat WH, Jaspers S, Peruski LF Jr, Lickteig RL, Johnson GL, et al. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol. 1993;13:2822\u201334.","journal-title":"Mol Cell Biol"},{"key":"10_CR77","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22:1027\u201349.","journal-title":"J Child Neurol"},{"key":"10_CR78","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1752-0509-3-70","volume":"3","author":"T Williamson","year":"2009","unstructured":"Williamson T, Schwartz JM, Kell DB, Stateva L. Deterministic mathematical models of the cAMP pathway in Saccharomyces cerevisiae. BMC Syst Biol. 2009;3:70.","journal-title":"BMC Syst Biol"},{"key":"10_CR79","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.bbapap.2011.04.015","volume":"1814","author":"CY Wu","year":"2011","unstructured":"Wu CY, Curtis A, Choi Y, Maeda M, Xu MJ, Berg A, et al. Identification of the phosphorylation sites in the survival motor neuron protein by protein kinase A. Biochim Biophys Acta. 2011;1814:1134\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"10_CR80","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1021\/jm200497t","volume":"54","author":"J Xiao","year":"2011","unstructured":"Xiao J, Marugan JJ, Zheng W, Titus S, Southall N, Cherry JJ, et al. Discovery, synthesis and biological evaluation of novel SMN protein modulators. J Med Chem. 2011;54:6215\u201333.","journal-title":"J Med Chem"},{"key":"10_CR81","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1212\/01.wnl.0000172860.41953.12","volume":"65","author":"T Zald\u00edvar","year":"2005","unstructured":"Zald\u00edvar T, Montejo Y, Acevedo AM, Guerra R, Vargas J, Garofalo N, et al. Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population. Neurology. 2005;65:636\u20138.","journal-title":"Neurology"},{"key":"10_CR82","doi-asserted-by":"publisher","first-page":"10126","DOI":"10.1074\/jbc.M110.183970","volume":"286","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Keleman O, Van Santen MA, Yelton SM, Wendlandt AE, Sviripa VM, et al. Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNA. J Biol Chem. 2011;286:10126\u201336.","journal-title":"J Biol Chem"},{"key":"10_CR83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-61779-833-7_3","volume":"880","author":"Z Zi","year":"2012","unstructured":"Zi Z. A tutorial on mathematical modeling of biological signaling pathways. Methods Mol Biol. 2012;880:41\u201351.","journal-title":"Methods Mol Biol"}],"container-title":["Advances in Neurobiology","Systems Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-94593-4_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T08:08:39Z","timestamp":1539763719000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-94593-4_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319945910","9783319945934"],"references-count":83,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-94593-4_10","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"type":"print","value":"2190-5215"},{"type":"electronic","value":"2190-5223"}],"subject":[],"published":{"date-parts":[[2018]]}}}